U.S. News, Released on 5/25/23
Elon Musk's brain-implant company Neuralink on Thursday said it had received U.S. Food and Drug Administration's (FDA) approval to launch first-in-human clinical study.
Elon Musk's Neuralink Gets U.S. FDA Approval for Human Clinical Study of Brain Implants added by Herman James on 05/25/2023View all posts by Herman James ?+'